Summary Of Nemolizumab - Innovative Product

Chemical Name

Nemolizumab

CAS No.

--

Molecular Formula

--

Innovator

Developer

Indication

Eczema

Therapeutic Area

Dermatology

Market Status

Phase 3

Approval Year

Patent Expiry